Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Carla Sellés Moreno"'
Autor:
Wolfgang Faigle, Carolina Cruciani, Witold Wolski, Bernd Roschitzki, Marco Puthenparampil, Paula Tomas-Ojer, Carla Sellés-Moreno, Thomas Zeis, Ivan Jelcic, Nicole Schaeren-Wiemers, Mireia Sospedra, Roland Martin
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Immune responses to citrullinated peptides have been described in autoimmune diseases like rheumatoid arthritis (RA) and multiple sclerosis (MS). We investigated the post-translational modification (PTM), arginine to citrulline, in brain tissue of MS
Externí odkaz:
https://doaj.org/article/86cec64a578c4a76a068f569debcf85b
Autor:
Roland Martin, Patrick Roth, Michael Weller, Luca Regli, Bernd Bodenmiller, Erich F. Greiner, Holger Moch, Mireia Sospedra, Andreas Lutterotti, Catherine J. Wu, Ron McKay, Joo Heon Shin, Barbara Schrörs, Susanne Dettwiler, Elisabeth Rushing, Daniel Schulz, Ivan Jelcic, Gioele Medici, Paula Tomas Ojer, Magdalena Foege, Carla Sellés Moreno, Reza Naghavian, Nora C. Toussaint, Marian C. Neidert, Tobias Weiss, Jian Wang
Designed mutations increase the stimulatory strength of D-neopeptides above N-peptides. (A) TILs were stimulated with 5 μM class I-peptides, including N-peptides and D-neopeptides, for 5 days. 5 replicate wells were tested for proliferation, and pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ceb25277d9242b2898736907629a9d6
https://doi.org/10.1158/1078-0432.22488566
https://doi.org/10.1158/1078-0432.22488566
Autor:
Roland Martin, Patrick Roth, Michael Weller, Luca Regli, Bernd Bodenmiller, Erich F. Greiner, Holger Moch, Mireia Sospedra, Andreas Lutterotti, Catherine J. Wu, Ron McKay, Joo Heon Shin, Barbara Schrörs, Susanne Dettwiler, Elisabeth Rushing, Daniel Schulz, Ivan Jelcic, Gioele Medici, Paula Tomas Ojer, Magdalena Foege, Carla Sellés Moreno, Reza Naghavian, Nora C. Toussaint, Marian C. Neidert, Tobias Weiss, Jian Wang
Predicted TSA/TAA-derived N-peptides and D-neopeptides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::076b20fe5359c6604ca16659aeb889ad
https://doi.org/10.1158/1078-0432.22488554.v1
https://doi.org/10.1158/1078-0432.22488554.v1
Autor:
Roland Martin, Patrick Roth, Michael Weller, Luca Regli, Bernd Bodenmiller, Erich F. Greiner, Holger Moch, Mireia Sospedra, Andreas Lutterotti, Catherine J. Wu, Ron McKay, Joo Heon Shin, Barbara Schrörs, Susanne Dettwiler, Elisabeth Rushing, Daniel Schulz, Ivan Jelcic, Gioele Medici, Paula Tomas Ojer, Magdalena Foege, Carla Sellés Moreno, Reza Naghavian, Nora C. Toussaint, Marian C. Neidert, Tobias Weiss, Jian Wang
Purpose:The low mutational load of some cancers is considered one reason for the difficulty to develop effective tumor vaccines. To overcome this problem, we developed a strategy to design neopeptides through single amino acid mutations to enhance th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194ce836ba5d5bdee824d491fbddf768
https://doi.org/10.1158/1078-0432.c.6532760
https://doi.org/10.1158/1078-0432.c.6532760
Autor:
Roland Martin, Patrick Roth, Michael Weller, Luca Regli, Bernd Bodenmiller, Erich F. Greiner, Holger Moch, Mireia Sospedra, Andreas Lutterotti, Catherine J. Wu, Ron McKay, Joo Heon Shin, Barbara Schrörs, Susanne Dettwiler, Elisabeth Rushing, Daniel Schulz, Ivan Jelcic, Gioele Medici, Paula Tomas Ojer, Magdalena Foege, Carla Sellés Moreno, Reza Naghavian, Nora C. Toussaint, Marian C. Neidert, Tobias Weiss, Jian Wang
Supplementary Table 1. Somatic mutations of the patient's glioblastoma; Supplementary Table 2. See Excel File; Supplementary Table 3. Literature-derived, glioblastoma-associated TAAs; Supplementary Table 4. See Excel File; Supplementary Table 5. Over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5715d4604cc355dbcad734a421599798
https://doi.org/10.1158/1078-0432.22488560.v1
https://doi.org/10.1158/1078-0432.22488560.v1
Autor:
Jian Wang, Tobias Weiss, Marian C. Neidert, Nora C. Toussaint, Reza Naghavian, Carla Sellés Moreno, Magdalena Foege, Paula Tomas Ojer, Gioele Medici, Ivan Jelcic, Daniel Schulz, Elisabeth Rushing, Susanne Dettwiler, Barbara Schrörs, Joo Heon Shin, Ron McKay, Catherine J. Wu, Andreas Lutterotti, Mireia Sospedra, Holger Moch, Erich F. Greiner, Bernd Bodenmiller, Luca Regli, Michael Weller, Patrick Roth, Roland Martin
Publikováno v:
Clinical Cancer Research, 28 (24)
Purpose: The low mutational load of some cancers is considered one reason for the difficulty to develop effective tumor vaccines. To overcome this problem, we developed a strategy to design neopeptides through single amino acid mutations to enhance t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d8dbb57d4e9eeaff591ab97ad18c938
https://www.zora.uzh.ch/id/eprint/221622/
https://www.zora.uzh.ch/id/eprint/221622/
Autor:
Witold Wolski, Nicole Schaeren-Wiemers, Thomas Zeis, Roland Martin, Mireia Sospedra, Paula Tomas-Ojer, Carla Sellés-Moreno, Marco Puthenparampil, Ivan Jelcic, Bernd Roschitzki, Carolina Cruciani, Wolfgang Faigle
Publikováno v:
Frontiers in Immunology, 10
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology
Immune responses to citrullinated peptides have been described in autoimmune diseases like rheumatoid arthritis (RA) and multiple sclerosis (MS). We investigated the post-translational modification (PTM), arginine to citrulline, in brain tissue of MS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddb2055d20d49ab845530db295fed3f5
Autor:
Carla Sellés-Moreno, Laia Grau-López, María José Mansilla, Cristina Ramo-Tello, Sara Fàbregas-Puig, Joan Amoedo, Aina Teniente-Serra, Juan Navarro-Barriuso, Eva Martínez-Cáceres
Publikováno v:
CNS neurosciencetherapeutics. 21(3)
Summary Background Treatment with tolerogenic dendritic cells (TolDC) is a promising, cell-based strategy to regulate autoimmune diseases such as multiple sclerosis (MS) in an antigen-specific way. This technique involves the use of TolDC from MS pat
Autor:
Cristina Ramo-Tello, Carla Sellés-Moreno, Laia Grau-López, Ricardo Pujol-Borrel, Eva Martínez-Cáceres
Publikováno v:
Europe PubMed Central
Journal of Translational Medicine
Journal of Translational Medicine, Vol 10, Iss Suppl 3, p P27 (2012)
Journal of Translational Medicine
Journal of Translational Medicine, Vol 10, Iss Suppl 3, p P27 (2012)
Background Specific cell therapy with tolerogenic Dendritic Cells (tolDCs) loaded with autoantigens is a promising tool for the attenuation of pathogenic T cells in autoimmune diseases such as Multiple Sclerosis (MS). The aim of this study was to ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d287c10b1516fea17df031a70e96f410
http://europepmc.org/abstract/PMC/PMC3509039
http://europepmc.org/abstract/PMC/PMC3509039